Beneficient (NasdaqCM:BENF) Q3 2026 Earnings call February 17, 2026 05:30 PM ET Company ParticipantsDan Callahan - Communications and Investor Relations ConsultantGiles Haycock - Managing DirectorGreg Ezell - CFOJames Silk - Interim CEOConference Call ParticipantsBrendan McCarthy - Equity Research AnalystOperatorHello, and thank you for standing by. Welcome to Beneficient's third quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation ...

Beneficient (NasdaqCM:BENF) Q3 2026 Earnings call February 17, 2026 05:30 PM ET Speaker5Hello, and thank you for standing by. Welcome to Beneficient's third quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star one one on your telephone. You would then hear an automated message advising your hand is raised. To withdraw you ...

The Hackett Group (NasdaqGS:HCKT) Q4 2025 Earnings call February 17, 2026 05:00 PM ET Company ParticipantsGeorge Sutton - Managing DirectorJeff Martin - Managing DirectorRob Ramirez - CFOTed Fernandez - Chairman and CEOVincent Colicchio - Managing DirectorOperatorWelcome to the Hackett Group Q4 Earnings Conference Call. Your lines have been placed on a listen-only mode until the question and answer session. Please be advised the conference is being recorded. Hosting tonight's call are Mr. Ted Fernandez, Cha ...

The Hackett Group (NasdaqGS:HCKT) Q4 2025 Earnings call February 17, 2026 05:00 PM ET Company ParticipantsGeorge Sutton - Managing DirectorJeff Martin - Managing DirectorRob Ramirez - CFOTed Fernandez - Chairman and CEOVincent Colicchio - Managing DirectorOperatorWelcome to the Hackett Group Q4 Earnings Conference Call. Your lines have been placed on a listen-only mode until the question and answer session. Please be advised the conference is being recorded. Hosting tonight's call are Mr. Ted Fernandez, Cha ...

Precision Optics (NasdaqCM:POCI) Q2 2026 Earnings call February 17, 2026 05:00 PM ET Company ParticipantsJoe Forkey - CEORobert Blum - Managing Partner and Managing Investor RelationsWayne Coll - CFOOperatorGood day, and welcome to the Precision Optics Reports second quarter fiscal year 2026 financial results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, ...

Precision Optics (NasdaqCM:POCI) Q2 2026 Earnings call February 17, 2026 05:00 PM ET Company ParticipantsJoe Forkey - CEORobert Blum - Managing Partner and Managing Investor RelationsWayne Coll - CFOOperatorGood day, and welcome to the Precision Optics Reports second quarter fiscal year 2026 financial results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by 0. After today's presentation, th ...

Financial Data and Key Metrics Changes - Caesars Entertainment reported full-year same-store enterprise net revenues increased by $266 million or 2% year-over-year [5] - Fourth quarter consolidated net revenues reached $2.9 billion, up 4% year-over-year, with adjusted EBITDA of $901 million, also up 2% year-over-year [5][6] - Digital segment achieved an all-time quarterly EBITDA record of $85 million despite poor volume in October [6] Business Line Data and Key Metrics Changes - Las Vegas segment reported same-store adjusted EBITDA of $447 million, down from $477 million last year, with occupancy at 92% compared to 96.5% last year [7] - Regional revenues increased by 4% year-over-year, driven by strong performance in Danville and New Orleans, although regional EBITDA declined slightly due to adverse weather conditions [7][10] - Digital segment net revenue for Q4 was $419 million, with adjusted EBITDA of $85 million, and full-year net revenues reached $1.4 billion, up 21% year-over-year [12][13] Market Data and Key Metrics Changes - Las Vegas occupancy improved sequentially, with a strong event calendar contributing to performance, including a record F1 event and a strong New Year's Eve [8][9] - Regional segment expected to benefit from a strong group mix in Reno and the transition of Windsor from managed to owned property [10] Company Strategy and Development Direction - The company is focused on reinvesting in its assets, with several upcoming CapEx projects in Las Vegas aimed at enhancing customer experiences [9] - The digital segment is expected to continue driving top-line growth, with a target of 20% growth and 50% flow-through to EBITDA [15][21] - The company is exploring opportunities in new markets, particularly in Virginia and Maine, while remaining cautious about skill games [34][77] Management's Comments on Operating Environment and Future Outlook - Management noted that leisure travel remains soft but is stabilizing, with expectations for group business to offset leisure softness in the near term [17][70] - The company anticipates a strong year ahead, particularly in the second half, driven by various events and renovations [19][72] - Management expressed optimism about the impact of tax refunds on consumer spending in 2026 [56][58] Other Important Information - The company is reducing debt while executing opportunistic share repurchases, with expectations of decreasing CapEx and interest expenses in 2026 [16] - Management highlighted the importance of Caesars Rewards as a competitive advantage in regional markets [64] Q&A Session Summary Question: Update on Las Vegas leisure customer trends - Management indicated that leisure travel is experiencing normal economic cycle activity, with group business helping fill gaps [28][30] Question: Expectations for iGaming legalization in Maine and Virginia - Management expressed optimism about Maine's potential launch and noted positive developments in Virginia's legislative process [32][34] Question: Insights on regional gaming pressures - Management acknowledged competitive pressures but emphasized the strength of Caesars Rewards as a differentiator [62][64] Question: Balancing debt reduction and buybacks with free cash flow - Management plans to be more active in share repurchases in the second quarter, balancing between debt reduction and buybacks [52] Question: Impact of tax refunds on consumer spending - Management believes tax refunds will provide a tailwind for consumer discretionary spending in 2026 [56][58] Question: Digital business performance and customer acquisition - Management reported improved retention and lower customer acquisition costs, contributing to growth in monthly active users [85]

Tactile Systems (NasdaqGM:TCMD) Q4 2025 Earnings call February 17, 2026 05:00 PM ET Company ParticipantsBen Haynor - Managing DirectorElaine Birkemeyer - CFOKyle Winborne - Equity ResearchSam Benzinger - Investor RelationsSheri Dodd - CEOConference Call ParticipantsBrandon Vasquez - Research AnalystNone - AnalystOperatorPlease stand by. Welcome, ladies and gentlemen, to the fourth quarter and full year 2025 earnings conference call for Tactile Medical. At this time, all participants have been placed in list ...

Rogers (NYSE:ROG) Q4 2025 Earnings call February 17, 2026 05:00 PM ET Company ParticipantsAli El-Haj - Interim President and CEOCraig Ellis - Senior Managing Director and Director of ResearchDaniel Moore - Director of ResearchLaura Russell - Senior Vice President and CFOSteve Haymore - Senior Director of Investor RelationsConference Call ParticipantsDavid Silver - Equity Research AnalystOperatorGood afternoon. My name is Kevin, and I'll be your conference operator today. At this time, I'd like to welcome ev ...

Financial Data and Key Metrics Changes - Total revenue for the full year 2025 was $329.5 million, a 12% increase year-over-year [4] - Adjusted EBITDA increased 21% year-over-year to $44.8 million [5] - Q4 revenue grew by 21% year-over-year to $103.6 million [29] - Gross margin for Q4 was 78.2%, up from 75.2% in Q4 2024 [29] - Net income increased 9% to $10.6 million, or $0.46 per diluted share [31] Business Line Data and Key Metrics Changes - Lymphedema revenue increased 16% year-over-year to $89.5 million in Q4 [6] - Airway clearance revenue increased 66% year-over-year to $14.1 million in Q4 [6] - For 2026, total revenue is expected to be in the range of $357 million to $365 million, representing year-over-year growth of 8% to 11% [6][32] Market Data and Key Metrics Changes - The Medicare channel remained strong in Q4, with patients moving directly to the Flexitouch Advanced pump under new NCD criteria [11] - The company expects a temporary short-term impact from the new Medicare prior authorization requirement for pneumatic compression devices [32][34] Company Strategy and Development Direction - The acquisition of LymphaTech is seen as a milestone in evolving from a product-based company to a comprehensive integrated solutions leader for lymphatic dysfunction [15][17] - Strategic priorities include improving access to care, expanding treatment options, and enhancing lifetime patient value [8][25] - The company plans to leverage AI-enabled technology to improve order processes and operational efficiency [21][22] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the new Medicare prior authorization requirements and expects to maintain growth in line with the overall lymphedema market [34][36] - The company is optimistic about the integration of LymphaTech and its potential to enhance patient care and streamline clinical workflows [15][53] Other Important Information - The company ended 2025 with $83.4 million in cash and cash equivalents and no outstanding borrowings [31] - The company repaid the full outstanding principal balance of $26.3 million on its term loan and repurchased $26.5 million of its stock [5] Q&A Session Summary Question: What drove the strong performance in the Lymphedema business in Q4? - Management noted multiple investments in people, processes, and technology, including strong CRM adoption and increased sales rep productivity [41] Question: How do the new prior authorization requirements balance with the tailwinds from the NCD? - Management indicated that the guidance reflects a balanced approach, incorporating both tailwinds from the NCD and the headwinds from prior authorization [44][45] Question: Can you elaborate on the LymphaTech acquisition and its commercialization model? - Management expressed excitement about integrating LymphaTech into their commercial engine and highlighted its potential for improving patient experience and workflow efficiency [51][53] Question: What are the expectations for EBITDA margins moving forward? - Management indicated that while EBITDA margins are expected to grow modestly, they anticipate further expansion in the long term as investments are annualized [66]